“Life science professionals make crucial decisions about prescription drugs, from advancing or terminating a novel compound to choosing a particular drug for individual patients. Lipomics is committed to providing accurate and quantitative metabolite profiles and authoritative interpretation of their meaning to assist in making these decisions.”
- Steve Watkins, Ph.D. Lipomics, Founder and President
TrueMass Profiling is a suite of analytical panels that provide comprehensive and quantitative coverage of key pathways involved in metabolic, cardiovascular and inflammatory conditions.
TrueMass Lipomic Panel quantifies up to 450 individual metabolites involved in structural and energetic lipid metabolism. The concentration and complete fatty acid composition of triglyceride, cholesterol ester, diglyceride, free fatty acid, phosphatidylcholine, phosphatidylethanolamine, phosphatidylserine, cardiolipin and lysophosphatidylcholine are determined producing a high resolution profile of basic lipid metabolism. TrueMass Lipomic Panel quantifies the lipid metabolites from almost any biological matrix including plasma, serum, tissues and cells. This platform is useful in profiling all diseases as structural and energetic lipids are central components of metabolism and integrated into virtually every biological process in the body.
TrueMass Fatty Acid Oxidation Panel profiles short- and long-chain acylcarnitines, intermediate products of mitochondrial β-oxidation—or fat burning—as well as free carnitine and its biosynthetic precursors to provide useful indices of energy balance, exercise intensity and fat utilization. Acylcarnitines provide valuable information for the study, diagnosis and understanding of metabolic disorders, myopathies, congestive heart failure and end stage renal disease.
TrueMass Cholesterol Metabolism Panel provides quantitative data on intermediates of sterol biosynthesis, sterol absorption and bile acid metabolism. Sterol intermediates and bile acids provide insight into processes involved in cholesterol synthesis, absorption and excretion, and are central to investigating cardiovascular and other disorders.
TrueView Display is a suite of tools designed to assist our clients in visualizing and displaying data generated from Lipomics TrueMass platforms.
Lipomic Surveyor reveals changes in metabolic status due to drug treatment or other intervention. It is a flexible and easy-to-use graphical interface for visualizing and interpreting results from TrueMass and other Lipomics assays. The Lipomic Surveyor organizes metabolites by families of fatty acid pathways in an interactive heat map using user specified parameters.